Atenolol 50mg tablets
Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Patient Information leaflet
(PIL)
21-04-2020
Summary of Product characteristics
(SPC)
02-01-2020
Public Assessment Report
(PAR)
20-04-2020
Active ingredient:
Atenolol
Available from:
Sterwin Medicines
ATC code:
C07AB03
INN (International Name):
Atenolol
Dosage:
50mg
Pharmaceutical form:
Oral tablet
Administration route:
Oral
Class:
No Controlled Drug Status
Prescription type:
Valid as a prescribable product
Product summary:
BNF: 02040000
Patient Information leaflet
PACKAGE LEAFLET: INFORMATION FOR
THE USER
Atenolol 25 mg Tablets
Atenolol 50 mg Tablets
Atenolol 100 mg Tablets
(ATENOLOL)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it
again.
•
If you have any further questions, ask your
doctor or your pharmacist.
•
This medicine has been prescribed for you
only. Do not pass it on to others. It may
harm them, even if their symptoms are the
same as yours.
•
If you get any side effects, talk to your
doctor or pharmacist. This includes any
possible side effects not listed in this leaflet.
See section 4.
WHAT IS IN THIS LEAFLET:
1. What Atenolol Tablets are and what they are
used for
2. What you need to know before you take
Atenolol Tablets
3. How to take Atenolol Tablets
4. Possible side effects
5. How to store Atenolol Tablets
6. Contents of the pack and other information 1.
WHAT ATENOLOL TABLETS ARE AND WHAT
THEY ARE USED FOR
Atenolol tablets contain the active ingredient
atenolol. Atenolol is one of a group of
medicines called beta blockers.
Atenolol Tablets are used
•
Treat high blood pressure (hypertension).
•
Treat uneven heart beats (arrhythmias).
•
Help prevent chest pain characterised by a
painful feeling of tightness in the chest
(angina pectoris);
•
Protect the heart in the early treatment after
a heart attack (myocardial infarction).
It works by making your heart beat more
slowly and with less force. 2.
WHAT YOU NEED TO KNOW BEFORE YOU
TAKE ATENOLOL TABLETS
DO NOT TAKE ATENOLOL TABLETS:
•
If you are allergic (hypersensitive) to
Atenolol or any of the other ingredients of
this medicine (listed in section 6).
•
If you have ever had any of the following
heart problems:
-heart failure which is not under control (this
usually makes you breathless and causes
your ankles to swell)
-second- or third-degree heart block
(a condition which may be treated by a
pacemaker)
-very slow or very uneven heart beats, very
low blood pressure or very
Read the complete document
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Atenolol 50mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Atenolol 50mg
For excipients, see 6.1.
3
PHARMACEUTICAL FORM
White, circular, biconvex, uncoated tablets with ‘FIL’ engraved
above the
score line, ‘50’ below the score line, on one side and plain on
the other side.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Atenolol 50mg tablets are indicated for the management of:
Hypertension
Angina pectoris
Cardiac arrhythmias
Acute myocardial infarction, as early intervention.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults:
_ _
_Hypertension: _
_ _
The majority of patients respond to a single oral dose of 100mg daily
though
some patients respond to 50mg, the effect being established fully
after one or
two weeks. A further reduction in blood pressure may be obtained by
combining atenolol tablets with other antihypertensive therapy such as
diuretics.
_Angina: _
The majority of patients respond to a single oral dose of 100mg daily
or to
50mg given twice daily. Increasing the dose above l00mg daily is
unlikely to
confer additional benefit.
_Cardiac arrhythmias. _
_ _
The initial dose for control of arrhythmias by intravenous application
of
atenolol is 2.5mg. This dose may be administered in intervals of 5
minutes
until the recommended effect is observed or until the maximum dose of
0.15mg per kg of body weight has been reached, respectively. When the
arrhythmia has been controlled with intravenous atenolol, the
recommended
oral maintenance dose of Atenolol tablets is a single daily dose of 50
- 100mg.
_ _
_Myocardial infarction: _
_ _
In those patients who are considered suitable for beta-blocker therapy
(presenting for treatment within 12 hours of the onset of chest pain),
appropriate intravenous beta-blocker therapy should be supplemented 15
minutes later by a single oral dose of 50mg atenolol
tablet providing intravenous therapy has been well tolerated. A
further oral
dose of
50mg Atenolol tablet should be given 12 hours later fo
Read the complete document
